2018
$94M
from 16 investors over 16 rounds
Verve Therapeutics raised $94M on January 19, 2021
Investors: GV, Wellington Management, Redmile Group, Novo Holdings, Logos Global Management, LP, Surveyor Capital and RA Capital Management, L.P.
Verve Therapeutics raised $63M on June 11, 2020
Investors: Biomatics Capital, ARCH Venture Partners, F-Prime Capital Partners, Casdin Capital, LLC, GV and Wellington Management
Verve Therapeutics raised $59M on May 7, 2019
Investors: ARCH Venture Partners, GV and F-Prime Capital Partners